We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPEN icon
2726
Opendoor
OPEN
$3.54B
$136K ﹤0.01%
121,461
+68,724
+130% +$132K
HEPS
2727
D-Market Electronic Services & Trading
HEPS
$1.02B
$136K ﹤0.01%
+206,563
New +$152K
MTTR
2728
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$136K ﹤0.01%
+48,500
New +$155K
GBIO
2729
DELISTED
Generation Bio
GBIO
$135K ﹤0.01%
3,447
+65
+2% +$3.41K
NOA
2730
North American Construction
NOA
$357M
$135K ﹤0.01%
10,118
-26,587
-72% -$328K
EFXT
2731
Enerflex
EFXT
$2.58B
$133K ﹤0.01%
+20,981
New +$122K
GATO
2732
DELISTED
Gatos Silver, Inc.
GATO
$131K ﹤0.01%
+31,931
New +$116K
ADAP
2733
DELISTED
Adaptimmune Therapeutics
ADAP
$130K ﹤0.01%
+89,171
New +$144K
PHX
2734
DELISTED
PHX Minerals
PHX
$128K ﹤0.01%
32,872
-79,000
-71% -$296K
NRDS icon
2735
NerdWallet
NRDS
$632M
$128K ﹤0.01%
+13,300
New +$149K
BKSY icon
2736
BlackSky Technology
BKSY
$843M
$127K ﹤0.01%
+10,345
New +$138K
BUR icon
2737
Burford Capital
BUR
$914M
$126K ﹤0.01%
+15,400
New +$127K
DMTK
2738
DELISTED
DermTech, Inc. Common Stock
DMTK
$125K ﹤0.01%
70,677
KALV
2739
DELISTED
KalVista Pharmaceuticals
KALV
$124K ﹤0.01%
+18,396
New +$98.5K
TOUR
2740
Tuniu
TOUR
$56.2M
$122K ﹤0.01%
+8,102
New +$89.1K
AMPS
2741
DELISTED
Altus Power
AMPS
$121K ﹤0.01%
18,600
+2,766
+17% +$22.6K
RITM icon
2742
Rithm Capital
RITM
$5.58B
$119K ﹤0.01%
14,580
-1,056,922
-99% -$8.82M
OPTXW icon
2743
CALL
Syntec Optics Holdings Warrant
OPTXW
$13.4M
$116K ﹤0.01%
11,657
XLE icon
2744
State Street Energy Select Sector SPDR ETF
XLE
$39B
$114K ﹤0.01%
+2,610
New +$114K
SEI
2745
Solaris Energy Infrastructure
SEI
$2.66B
$113K ﹤0.01%
11,400
-8,428
-43% -$92.3K
FULC icon
2746
Fulcrum Therapeutics
FULC
$241M
$113K ﹤0.01%
15,526
-4,589
-23% -$29.9K
PRM icon
2747
Perimeter Solutions
PRM
$5.66B
$112K ﹤0.01%
+12,288
New +$108K
EAF icon
2748
GrafTech
EAF
$184M
$112K ﹤0.01%
2,350
-54,885
-96% -$2.67M
CAPR icon
2749
Capricor Therapeutics
CAPR
$109K ﹤0.01%
+28,359
New +$135K
ASML icon
2750
ASML
ASML
$596B
$109K ﹤0.01%
+200
New +$105K

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.